First National Bank of South Miami’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-225
Closed -$30K 269
2022
Q4
$30K Hold
225
0.02% 210
2022
Q3
$26K Hold
225
0.02% 217
2022
Q2
$26K Hold
225
0.02% 230
2022
Q1
$29K Hold
225
0.02% 242
2021
Q4
$34K Hold
225
0.02% 242
2021
Q3
$36K Hold
225
0.02% 231
2021
Q2
$37K Hold
225
0.03% 224
2021
Q1
$34K Sell
225
-77
-25% -$12.2K 0.03% 217
2020
Q4
$46K Hold
302
0.04% 188
2020
Q3
$41K Sell
302
-50
-14% -$6.78K 0.04% 179
2020
Q2
$48K Hold
352
0.05% 161
2020
Q1
$38K Buy
352
+127
+56% +$14.6K 0.05% 165
2019
Q4
$27K Hold
225
0.03% 192
2019
Q3
$23K Hold
225
0.02% 213
2019
Q2
$24K Hold
225
0.02% 216
2019
Q1
$25K Hold
225
0.02% 213
2018
Q4
$25K Buy
+225
New +$23.9K 0.02% 214

Other funds holding IBB

First National Bank of South Miami's IBB Position: Q1 2023 in Review

First National Bank of South Miami sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 225 shares — an estimated $30K sold.

First National Bank of South Miami first reported a position in IBB in Q4 2018 and held it in 17 quarters. The position peaked at $48K in Q2 2020. 867 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

  • First National Bank of South Miami reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
  • First National Bank of South Miami sold 225 iShares Biotechnology ETF shares in Q1 2023, an estimated $30K.
  • First National Bank of South Miami first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 17 quarters.
  • First National Bank of South Miami's iShares Biotechnology ETF position peaked at $48K in Q2 2020.
  • 867 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on First National Bank of South Miami's 13F filing for Q1 2023, filed 17 Apr 2023.